bioRxivNeurosciencePreprint
Dysregulated functional and metabolic response in multiple sclerosis patient macrophages correlate with a more inflammatory state, reminiscent of trained immunity
Jennifer FranssoniD, Corinne BacheliniD, Florence Deknuydt, Farid IchouiD, Léna Guillot‐NoëliD, Maharajah PonnaiahiD, Arnaud GloagueniD, Élisabeth MaillartiD, Bruno StankoffiD, Arthur TenenhausiD, Fanny MocheliD, Bertrand FontaineiD, Céline LouapreiD, Violetta ZujoviciD
Abstract
In multiple sclerosis (MS), immune cells invade the central nervous system and destroy myelin. Macrophages contribute to demyelination and myelin repair, and their role in each process depends on their ability to acquire specific phenotypes in response to external signals. Here, we assess whether defects in MS patient macrophage responses may lead to increased inflammation or lack of neuro-regenerative effects. To test this hypothesis, CD14+CD16- monocytes from MS patients and healthy controls were activated in vitro to obtain homeostatic-like, pro-inflammatory and pro-regenerative macrophages. Myelin phagocytic capacity and surface molecule expression of CD14, CD16 and HLA-DR were evaluated with flow cytometry. In parallel, macrophages were assessed through RNA sequencing and metabolomics. We observed that MS patient monocytes ex vivo recapitulate their preferential activation toward a CD16+ phenotype, a subset of pro-inflammatory cells present in MS lesions. Even in the absence of pro-inflammatory stimuli, MS patient macrophages exhibit a pro-inflammatory transcriptomic profile with higher levels of cytokine/chemokine suggesting increased recruitment capacities. Interestingly, MS patient macrophages exhibit a specific metabolic signature with a mitochondrial energy metabolism blockage resulting in a shift from oxidative phosphorylation to glycolysis. Furthermore, we observe a failure to up-regulate apoptosis effector genes in the pro inflammatory state suggesting a longer-lived pro-inflammatory macrophage population. Our results highlight an intrinsic defect of MS patient macrophages that provide evidence of innate immune cell memory in MS.
- organism: human
- assay: bulk RNA-seq
- assay: metabolomics
- research focus: differential expression
- approach: statistical model
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteomic analysis reveals dysregulation of peripheral blood neutrophils in patients with Multiple Sclerosis
Katie J Smith, Zachary Lim, … Emily Gwyer Findlay·Clinical & Experimental ImmunologyPeer-reviewed·Dec 9, 2024
- EMMPRIN confers metabolic advantage for monocytes and macrophages to promote disease in a model of multiple sclerosis
D. K. Kaushik, A. Das, … V. W. Yong·Journal of NeuroinflammationPeer-reviewed·Aug 15, 2026
- Mitochondrial Dysfunction Rewires Macrophage Metabolism, Driving Pro-inflammatory Priming and Immune System Remodeling
Nikita Markov, Aref Hosseini, … Hans‐Uwe Simon·bioRxiv·Nov 1, 2025
- Mapping Leukocyte Dynamics during Neuroinflammation Identifies Meningeal Monocyte-Derived Macrophages as Drivers of Progressive Disease
Juan Villar-Vesga, Pauline Clément, … Sarah Mundt·bioRxiv·Aug 15, 2025
- Maresin-1 promotes neuroprotection and prevents disease progression in experimental models of multiple sclerosis through metabolic reprogramming and shaping innate and adaptive disease-associated cell types
Insha Zahoor, Mohammad Nematullah, … Shailendra Giri·bioRxiv·Sep 25, 2023
- Maintenance of chronic neuroinflammation in multiple sclerosis via interferon signaling and CD8 T cell-mediated cytotoxicity
Syed Ali Raza, Yoshimi Enose‐Akahata, … Daniel S. Reich·bioRxiv·Jun 9, 2025